<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>RedHill Biopharma Ltd</title>
	<atom:link href="http://www.redhillbio.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.redhillbio.com</link>
	<description></description>
	<lastBuildDate>Tue, 15 May 2012 15:13:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>RedHill Biopharma commenced advanced clinical trial with RHB-103 (migraine)</title>
		<link>http://www.redhillbio.com/news/redhill-biopharma-commenced-advanced-clinical-trial-with-rhb-103-migraine/</link>
		<comments>http://www.redhillbio.com/news/redhill-biopharma-commenced-advanced-clinical-trial-with-rhb-103-migraine/#comments</comments>
		<pubDate>Tue, 24 Apr 2012 10:10:59 +0000</pubDate>
		<dc:creator>AdiFrish</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.redhillbio.com/?p=960</guid>
		<description><![CDATA[RedHill Biopharma commenced advanced clinical trial with RHB-103 (Migraine) (April 24 2012) English &#160; RedHill Biopharma commenced advanced clinical trial with RHB-103 (Migraine) (April 24 2012) Hebrew]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.redhillbio.com/wp-content/uploads/2012/04/RedHill-Biopharma-commenced-advanced-clinical-trial-with-RHB-103-Migraine-April-24-2012-English.pdf">RedHill Biopharma commenced advanced clinical trial with RHB-103 (Migraine) (April 24 2012) English</a></p>
<p>&nbsp;</p>
<p><a href="http://www.redhillbio.com/wp-content/uploads/2012/04/RedHill-Biopharma-commenced-advanced-clinical-trial-with-RHB-103-Migraine-April-24-2012-Hebrew.pdf">RedHill Biopharma commenced advanced clinical trial with RHB-103 (Migraine) (April 24 2012) Hebrew</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.redhillbio.com/news/redhill-biopharma-commenced-advanced-clinical-trial-with-rhb-103-migraine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RedHill Biopharma announces successful pivotal bioequivalence trial results with RHB-102 (prevention of nausea and vomiting)</title>
		<link>http://www.redhillbio.com/news/redhill-biopharma-announces-successful-pivotal-bioequivalence-trial-results-with-rhb-102-prevention-of-nausea-and-vomiting/</link>
		<comments>http://www.redhillbio.com/news/redhill-biopharma-announces-successful-pivotal-bioequivalence-trial-results-with-rhb-102-prevention-of-nausea-and-vomiting/#comments</comments>
		<pubDate>Wed, 18 Apr 2012 15:18:54 +0000</pubDate>
		<dc:creator>AdiFrish</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.redhillbio.com/?p=947</guid>
		<description><![CDATA[RedHill announces successful pivotal BE trial results with RHB-102 (nausea and vomiting) &#8211; April 17, 2012 RedHill announces successful pivotal BE trial results with RHB-102 (nausea and vomiting) &#8211; Hebrew &#8211; April 17, 2012 See Dror Ben Asher (CEO) and Gilead Raday&#8217;s (VP Product Development) TV interview regarding RHB-102 trial results (Hebrew): http://www.bizportal.co.il/shukhahon/biznews02.shtml?mid=315186&#38;strsrh=רדהיל &#160; &#160;]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.redhillbio.com/wp-content/uploads/2012/04/RedHill-announces-successful-pivotal-BE-trial-results-with-RHB-102-nausea-and-vomiting-April-17-2012.pdf">RedHill announces successful pivotal BE trial results with RHB-102 (nausea and vomiting) &#8211;  April 17, 2012</a></p>
<p><a href="http://www.redhillbio.com/wp-content/uploads/2012/04/RedHill-announces-successful-pivotal-BE-trial-results-with-RHB-102-nausea-and-vomiting-Hebrew-April-17-20122.pdf">RedHill announces successful pivotal BE trial results with RHB-102 (nausea and vomiting) &#8211; Hebrew &#8211;  April 17, 2012</a></p>
<p>See Dror Ben Asher (CEO) and Gilead Raday&#8217;s (VP Product Development) TV interview regarding RHB-102 trial results (Hebrew):</p>
<p><a href="http://www.bizportal.co.il/shukhahon/biznews02.shtml?mid=315186&amp;strsrh=רדהיל">http://www.bizportal.co.il/shukhahon/biznews02.shtml?mid=315186&amp;strsrh=רדהיל</a></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.redhillbio.com/news/redhill-biopharma-announces-successful-pivotal-bioequivalence-trial-results-with-rhb-102-prevention-of-nausea-and-vomiting/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RedHill Biopharma&#8217;s RHB-102 (prevention of nausea and vomiting) featured by the Israeli Ministry of Foreign Affairs</title>
		<link>http://www.redhillbio.com/news/redhill-biopharmas-rhb-102-prevention-of-nausea-and-vomiting-featured-by-the-israeli-ministry-of-foreign-affairs/</link>
		<comments>http://www.redhillbio.com/news/redhill-biopharmas-rhb-102-prevention-of-nausea-and-vomiting-featured-by-the-israeli-ministry-of-foreign-affairs/#comments</comments>
		<pubDate>Mon, 05 Mar 2012 13:43:01 +0000</pubDate>
		<dc:creator>AdiFrish</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.redhillbio.com/?p=941</guid>
		<description><![CDATA[http://www.mfa.gov.il/MFA/InnovativeIsrael/No-more-nausea-after-chemo-1-Mar-2012]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.mfa.gov.il/MFA/InnovativeIsrael/No-more-nausea-after-chemo-1-Mar-2012">http://www.mfa.gov.il/MFA/InnovativeIsrael/No-more-nausea-after-chemo-1-Mar-2012</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.redhillbio.com/news/redhill-biopharmas-rhb-102-prevention-of-nausea-and-vomiting-featured-by-the-israeli-ministry-of-foreign-affairs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RedHill Biopharma&#8217;s RHB-102 (prevention of nausea and vomiting) advanced clinical trial has began</title>
		<link>http://www.redhillbio.com/news/redhill-biopharmas-rhb-102-prevention-of-nausea-and-vomiting-advanced-clinical-trial-has-began/</link>
		<comments>http://www.redhillbio.com/news/redhill-biopharmas-rhb-102-prevention-of-nausea-and-vomiting-advanced-clinical-trial-has-began/#comments</comments>
		<pubDate>Wed, 15 Feb 2012 11:34:14 +0000</pubDate>
		<dc:creator>AdiFrish</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.redhillbio.com/?p=937</guid>
		<description><![CDATA[RedHill Biopharma commences advanced clinical trial with RHB-102 (Nausea and Vomiting) (February 14 2012) RedHill Biopharma commenced advanced clincial trial with RHB-102 (Nausea and Vomiting) (February 14 2012) Hebrew]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.redhillbio.com/wp-content/uploads/2012/02/RedHill-Biopharma-commences-advanced-clinical-trial-with-RHB-102-Nausea-and-Vomiting-February-14-2012.pdf">RedHill Biopharma commences advanced clinical trial with RHB-102 (Nausea and Vomiting) (February 14 2012)</a></p>
<p><a href="http://www.redhillbio.com/wp-content/uploads/2012/02/RedHill-Biopharma-commenced-advanced-clincial-trial-with-RHB-102-Nausea-and-Vomiting-February-14-2012-Hebrew.pdf">RedHill Biopharma commenced advanced clincial trial with RHB-102 (Nausea and Vomiting) (February 14 2012) Hebrew</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.redhillbio.com/news/redhill-biopharmas-rhb-102-prevention-of-nausea-and-vomiting-advanced-clinical-trial-has-began/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RedHill Biopharma obtains FDA IND for advanced clinical trial with RHB-102 (prevention of nausea and vomiting)</title>
		<link>http://www.redhillbio.com/news/redhill-biopharma-obtains-fda-ind-for-advanced-clinical-trial-with-rhb-102-prevention-of-nausea-and-vomiting/</link>
		<comments>http://www.redhillbio.com/news/redhill-biopharma-obtains-fda-ind-for-advanced-clinical-trial-with-rhb-102-prevention-of-nausea-and-vomiting/#comments</comments>
		<pubDate>Mon, 13 Feb 2012 08:59:50 +0000</pubDate>
		<dc:creator>AdiFrish</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.redhillbio.com/?p=927</guid>
		<description><![CDATA[RedHill Biopharma obtains FDA IND for advanced clinical trial with RHB-102 (Nausea and Vomiting) Feb 12th 2012 RedHill Biopharma obtains FDA IND for advanced clinical trial with RHB-102 (Nausea and Vomiting) Feb 12th 2012 (Hebrew)]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.redhillbio.com/wp-content/uploads/2012/02/RedHill-Biopharma-obtains-FDA-IND-for-advanced-clinical-trial-with-RHB-102-Nausea-and-Vomiting-Feb-12th-20121.pdf">RedHill Biopharma obtains FDA IND for advanced clinical trial with RHB-102 (Nausea and Vomiting) Feb 12th 2012</a></p>
<p><a href="http://www.redhillbio.com/wp-content/uploads/2012/02/RedHill-Biopharma-obtains-FDA-IND-for-advanced-clinical-trial-with-RHB-102-Nausea-and-Vomiting-Feb-12th-2012-Hebrew1.pdf">RedHill Biopharma obtains FDA IND for advanced clinical trial with RHB-102 (Nausea and Vomiting) Feb 12th 2012 (Hebrew)</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.redhillbio.com/news/redhill-biopharma-obtains-fda-ind-for-advanced-clinical-trial-with-rhb-102-prevention-of-nausea-and-vomiting/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RedHill Biopharma obtains a CTA approval from Health Canada to commence an advanced trial with RHB-102 (prevention of nausea &amp; vomiting)</title>
		<link>http://www.redhillbio.com/news/redhill-biopharma-obtains-a-cta-approval-from-health-canada-to-commence-an-advanced-trial-with-rhb-102-nausea-vomiting/</link>
		<comments>http://www.redhillbio.com/news/redhill-biopharma-obtains-a-cta-approval-from-health-canada-to-commence-an-advanced-trial-with-rhb-102-nausea-vomiting/#comments</comments>
		<pubDate>Tue, 07 Feb 2012 14:56:54 +0000</pubDate>
		<dc:creator>AdiFrish</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.redhillbio.com/?p=916</guid>
		<description><![CDATA[RedHill Biopharma obtains a CTA approval to commence an advanced trial with RHB-102 (prevention of nausea &#38; vomiting) (February 5th 2012) RedHill Biopharma obtains a CTA approval to commence an advanced trial with RHB-102 (prevention of nausea &#38; vomiting) (February 5th 2012) Hebrew]]></description>
			<content:encoded><![CDATA[<p dir="ltr"><a href="http://www.redhillbio.com/wp-content/uploads/2012/02/RedHill-Biopharma-obtains-a-CTA-approval-to-commence-an-advanced-trial-with-RHB-102-prevention-of-nausea-vomiting-February-5th-20122.pdf">RedHill Biopharma obtains a CTA approval to commence an advanced trial with RHB-102 (prevention of nausea &amp; vomiting) (February 5th 2012)</a></p>
<p dir="ltr"><a href="http://www.redhillbio.com/wp-content/uploads/2012/02/RedHill-Biopharma-obtains-a-CTA-approval-to-commence-an-advanced-trial-with-RHB-102-prevention-of-nausea-vomiting-February-5th-2012-Hebrew.pdf">RedHill Biopharma obtains a CTA approval to commence an advanced trial with RHB-102 (prevention of nausea &amp; vomiting) (February 5th 2012) Hebrew</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.redhillbio.com/news/redhill-biopharma-obtains-a-cta-approval-from-health-canada-to-commence-an-advanced-trial-with-rhb-102-nausea-vomiting/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mr. Gilead Raday&#8217;s interview on Israel21c, regarding RHB-102 (prevention of nausea &amp; vomiting in cancer patients)</title>
		<link>http://www.redhillbio.com/news/mr-gilead-radays-interview-on-israel21c-regarding-rhb-102-prevention-of-nausea-vomiting-in-cancer-patient/</link>
		<comments>http://www.redhillbio.com/news/mr-gilead-radays-interview-on-israel21c-regarding-rhb-102-prevention-of-nausea-vomiting-in-cancer-patient/#comments</comments>
		<pubDate>Thu, 02 Feb 2012 12:54:27 +0000</pubDate>
		<dc:creator>AdiFrish</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.redhillbio.com/?p=913</guid>
		<description><![CDATA[See Mr. Gilead Raday&#8217;s interview on Israel21c, regarding RHB-102 (prevention of nausea &#38; vomiting in cancer patients): http://israel21c.org/health/daily-pill-to-vanquish-nausea-after-chemo]]></description>
			<content:encoded><![CDATA[<p>See Mr. Gilead Raday&#8217;s interview on Israel21c, regarding RHB-102 (prevention of nausea &amp; vomiting in cancer patients):</p>
<p><a href="http://israel21c.org/health/daily-pill-to-vanquish-nausea-after-chemo">http://israel21c.org/health/daily-pill-to-vanquish-nausea-after-chemo</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.redhillbio.com/news/mr-gilead-radays-interview-on-israel21c-regarding-rhb-102-prevention-of-nausea-vomiting-in-cancer-patient/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>IntelGenx, RedHill&#8217;s Development Partner in RHB-103 (Migraine) Announces Health Canada Approval for Pivotal Trial</title>
		<link>http://www.redhillbio.com/news/intelgenx-redhills-development-partner-in-rhb-103-migraine-announce-health-canada-approval-for-pivotal-trial-2/</link>
		<comments>http://www.redhillbio.com/news/intelgenx-redhills-development-partner-in-rhb-103-migraine-announce-health-canada-approval-for-pivotal-trial-2/#comments</comments>
		<pubDate>Mon, 02 Jan 2012 08:55:09 +0000</pubDate>
		<dc:creator>AdiFrish</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.redhillbio.com/?p=904</guid>
		<description><![CDATA[IntelGenx, RedHill&#8217;s Development Partner in RHB-103 (Migraine) Announces Health Canada Approval for Pivotal Trial]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.redhillbio.com/wp-content/uploads/2012/01/IntelGenx-RedHills-Development-Partner-in-RHB-103-Migraine-Announces-Health-Canada-Approval-for-Pivotal-Trial-1.pdf">IntelGenx, RedHill&#8217;s Development Partner in RHB-103 (Migraine) Announces Health Canada Approval for Pivotal Trial</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.redhillbio.com/news/intelgenx-redhills-development-partner-in-rhb-103-migraine-announce-health-canada-approval-for-pivotal-trial-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dr. Jeff Lehighton presents RedHill Biopharma on Bloomberg TV</title>
		<link>http://www.redhillbio.com/news/dr-jeff-lehighton-presents-redhill-biopharma-on-bloomberg-tv/</link>
		<comments>http://www.redhillbio.com/news/dr-jeff-lehighton-presents-redhill-biopharma-on-bloomberg-tv/#comments</comments>
		<pubDate>Wed, 23 Nov 2011 11:46:37 +0000</pubDate>
		<dc:creator>AdiFrish</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.redhillbio.com/?p=878</guid>
		<description><![CDATA[Please use the link below to watch Dr. Jeff Lehighton, RedHill Biopharma&#8217;s Chairman of the Advisory Board, on Bloomberg TV: http://www.bloomberg.com/video/80653140/]]></description>
			<content:encoded><![CDATA[<p>Please use the link below to watch Dr. Jeff Lehighton, RedHill Biopharma&#8217;s Chairman of the Advisory Board, on Bloomberg TV:</p>
<p><a href="http://www.bloomberg.com/video/80653140/">http://www.bloomberg.com/video/80653140/</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.redhillbio.com/news/dr-jeff-lehighton-presents-redhill-biopharma-on-bloomberg-tv/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RedHill Biopharma engages with CRO for potential pivotal trial with RHB-102 (prevention of nausea &amp; vomiting in cancer patients)</title>
		<link>http://www.redhillbio.com/news/redhill-biopharma-engages-with-cro-for-potential-pivotal-trial-with-rhb-102-prevention-of-nausea-vomiting-in-cancer-patients/</link>
		<comments>http://www.redhillbio.com/news/redhill-biopharma-engages-with-cro-for-potential-pivotal-trial-with-rhb-102-prevention-of-nausea-vomiting-in-cancer-patients/#comments</comments>
		<pubDate>Fri, 04 Nov 2011 16:07:44 +0000</pubDate>
		<dc:creator>AdiFrish</dc:creator>
				<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.redhillbio.com/?p=865</guid>
		<description><![CDATA[RedHill engages with CRO for potential pivotal trial with RHB-102 (Prevention of Nausea Vomiting ) (Hebrew) RedHill engages with CRO in preparation for potential pivotal trial with RHB-102 (prevention of nausea &#38; vomiting )]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.redhillbio.com/wp-content/uploads/2011/11/RedHill-engages-with-CRO-for-potential-pivotal-trial-with-RHB-102-Prevention-of-Nausea-Vomiting-Hebrew.pdf">RedHill engages with CRO for potential pivotal trial with RHB-102 (Prevention of Nausea Vomiting ) (Hebrew)</a></p>
<p><a href="http://www.redhillbio.com/wp-content/uploads/2011/11/RedHill-engages-with-CRO-in-preparation-for-potential-pivotal-trial-with-RHB-102-prevention-of-nausea-vomiting-2.pdf">RedHill engages with CRO in preparation for potential pivotal trial with RHB-102 (prevention of nausea &amp; vomiting )</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.redhillbio.com/news/redhill-biopharma-engages-with-cro-for-potential-pivotal-trial-with-rhb-102-prevention-of-nausea-vomiting-in-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

